DexCom
DXCM
722 hedge funds and large institutions have $37.4B invested in DexCom in 2020 Q2 according to their latest regulatory filings, with 192 funds opening new positions, 251 increasing their positions, 223 reducing their positions, and 60 closing their positions.
220% more first-time investments, than exits
New positions opened: 192 | Existing positions closed: 60
52% more capital invested
Capital invested by funds: $24.7B → $37.4B (+$12.8B)
22% more funds holding in top 10
Funds holding in top 10: 18 → 22 (+4)
22% more funds holding
Funds holding: 593 → 722 (+129)
13% more repeat investments, than reductions
Existing positions increased: 251 | Existing positions reduced: 223
7% more call options, than puts
Call options by funds: $463M | Put options by funds: $434M
0.04% more ownership
Funds ownership: 400.17% → 400.21% (+0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$658M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$548M |
| 3 |
Sands Capital Management
Arlington,
Virginia
|
+$481M |
| 4 |
BlackRock
New York
|
+$411M |
| 5 |
Goldman Sachs
New York
|
+$208M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$477M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$250M |
| 3 |
D.E. Shaw & Co
New York
|
-$212M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$207M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$160M |
DXCM Hedge Fund Activity: Q2 2020 in Review
722 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q2 2020, worth a combined $37.4B — up 52% from $24.7B a quarter earlier.
Buyers outnumbered sellers: 192 funds opened new DXCM positions and 60 closed out — a net gain of 132 holders — while 251 added to existing stakes and 223 trimmed.
The largest buyer was State Street, adding an estimated $658M. The largest seller was T. Rowe Price Associates, cutting an estimated $477M.
- 722 institutional investors held DexCom (DXCM) as of Q2 2020, up from 593 in Q1 2020.
- Funds reported $37.4B of DexCom stock for Q2 2020, up 52% quarter-over-quarter.
- 192 funds opened new DexCom positions in Q2 2020 and 60 closed out, a net change of +132 holders.
- The largest DexCom buyer in Q2 2020 was State Street, an estimated $658M added.
- The largest DexCom seller in Q2 2020 was T. Rowe Price Associates, an estimated $477M sold.
Based on aggregated 13F filings for Q2 2020.